Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 122,986,656
  • Shares Outstanding, K 1,467,096
  • Annual Sales, $ 14,240 M
  • Annual Income, $ 1,591 M
  • 60-Month Beta 0.79
  • Price/Sales 8.58
  • Price/Cash Flow 28.61
  • Price/Book 5.94
Trade BSX with:

Options Overview Details

View History
  • Implied Volatility 18.20% ( -0.67%)
  • Historical Volatility 14.29%
  • IV Percentile 32%
  • IV Rank 22.22%
  • IV High 30.51% on 07/18/24
  • IV Low 14.68% on 08/13/24
  • Put/Call Vol Ratio 0.75
  • Today's Volume 10,494
  • Volume Avg (30-Day) 6,385
  • Put/Call OI Ratio 1.28
  • Today's Open Interest 204,629
  • Open Int (30-Day) 195,453

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.58
  • Number of Estimates 12
  • High Estimate 0.59
  • Low Estimate 0.57
  • Prior Year 0.50
  • Growth Rate Est. (year over year) +16.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
75.53 +10.30%
on 08/14/24
84.11 -0.96%
on 09/13/24
+7.39 (+9.73%)
since 08/13/24
3-Month
71.88 +15.90%
on 08/05/24
84.11 -0.96%
on 09/13/24
+6.35 (+8.25%)
since 06/13/24
52-Week
48.35 +72.31%
on 10/13/23
84.11 -0.96%
on 09/13/24
+30.11 (+56.60%)
since 09/13/23

Most Recent Stories

More News
Factors Driving Veeva Stock More Than 20% in Three Months

Shares of Veeva Systems VEEV have risen 20.5% in the past three months, outperforming both the industry as well as the S&P 500 Index. The outperformance was primarily driven by its strong quarterly results...

BSX : 83.31 (-0.62%)
DGX : 154.38 (-0.25%)
DVA : 163.56 (+3.76%)
VEEV : 217.95 (-0.90%)
SYK Stocks Gains Following Expansion of Foot & Ankle Portfolio

Stryker SYK recently announced the expansion of its Foot & Ankle portfolio with the introduction of two cutting-edge products — the Osteotomy Truss System (“OTS”) and the Ankle Truss System (“ATS”)....

BSX : 83.31 (-0.62%)
DGX : 154.38 (-0.25%)
SYK : 370.25 (+0.67%)
DVA : 163.56 (+3.76%)
Medtronic Keeps Capturing High-Growth Markets: Time to Buy MDT Stock?

The past month has been quite encouraging for Medtronic MDT investors. Solid first-quarter fiscal 2025 organic growth performance and several strategic initiatives to revamp the bottom line, including...

ABT : 116.40 (-0.37%)
BSX : 83.31 (-0.62%)
BDX : 234.18 (-0.56%)
MDT : 90.00 (unch)
VEEV Stock Up Following the Release of New Features of Veeva Site Connect

Veeva Systems Inc. VEEV recently announced the newest release of Veeva Site Connect. The release adds powerful new capabilities and a streamlined site-centric experience to simplify and standardize sponsor-site...

BSX : 83.31 (-0.62%)
DGX : 154.38 (-0.25%)
DVA : 163.56 (+3.76%)
VEEV : 217.95 (-0.90%)
COO Stock Up 0.4% Following the Launch of New Inserter for Paragard IUD

The Cooper Companies, Inc.’s COO business segment, CooperSurgical (CSI), announced the launch of a new inserter designed for single-hand placement of Paragard on Tuesday, which was recently approved...

BSX : 83.31 (-0.62%)
DGX : 154.38 (-0.25%)
DVA : 163.56 (+3.76%)
COO : 110.53 (+1.53%)
3 'Strong Buy' Stocks to Grab Now for More Gains

For investors looking to add some high-potential stocks to their portfolio, here are three top-rated opportunities to consider now.

$SPX : 5,626.02 (+0.54%)
BSX : 83.31 (-0.62%)
PH : 591.33 (+0.64%)
LDOS : 155.50 (+1.16%)
1 Dividend Aristocrat to Buy at a Discount This September

This dividend-paying stock is trading at an attractive valuation, making it a solid pick for investors seeking value and steady income.

MDT : 90.00 (unch)
BSX : 83.31 (-0.62%)
Is Boston Scientific Stock Outperforming the Nasdaq?

Boston Scientific has outperformed the Nasdaq Composite over the past year, and analysts remain bullish on the stock’s prospects.

BSX : 83.31 (-0.62%)
$NASX : 17,683.98 (+0.65%)
MDT : 90.00 (unch)
Catalent's Stock Gains on Q4 Earnings Beat, Gross Margin Up

Catalent, Inc. CTLT reported fourth-quarter fiscal 2024 adjusted earnings per share (EPS) of 65 cents, which was significantly up from the year-ago period’s EPS of 2 cents. The figure surpassed the Zacks...

BSX : 83.31 (-0.62%)
DGX : 154.38 (-0.25%)
DVA : 163.56 (+3.76%)
CTLT : 59.62 (-0.12%)
COO Stock Gains on Q3 Earnings & Revenue Beat, Margins Up

The Cooper Companies, Inc. COO delivered adjusted earnings per share (EPS) of 96 cents in the third quarter of fiscal 2024, which improved 14.3% year over year. The figure surpassed the Zacks Consensus...

BSX : 83.31 (-0.62%)
DGX : 154.38 (-0.25%)
DVA : 163.56 (+3.76%)
COO : 110.53 (+1.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and...

See More

Key Turning Points

3rd Resistance Point 84.84
2nd Resistance Point 84.48
1st Resistance Point 83.89
Last Price 83.31
1st Support Level 82.94
2nd Support Level 82.58
3rd Support Level 82.00

See More

52-Week High 84.11
Last Price 83.31
Fibonacci 61.8% 70.45
Fibonacci 50% 66.23
Fibonacci 38.2% 62.01
52-Week Low 48.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar